1,484 Shares in DaVita Inc. (NYSE:DVA) Bought by World Investment Advisors

World Investment Advisors purchased a new position in shares of DaVita Inc. (NYSE:DVA) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 1,484 shares of the company’s stock, valued at approximately $222,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. MML Investors Services LLC raised its stake in DaVita by 1.3% during the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock worth $869,000 after acquiring an additional 68 shares in the last quarter. Exchange Traded Concepts LLC increased its stake in DaVita by 8.3% in the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after purchasing an additional 68 shares during the period. Impact Partnership Wealth LLC boosted its holdings in shares of DaVita by 3.7% in the fourth quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock valued at $290,000 after acquiring an additional 70 shares in the last quarter. Contravisory Investment Management Inc. boosted its holdings in shares of DaVita by 1.2% in the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after acquiring an additional 73 shares in the last quarter. Finally, Nilsine Partners LLC boosted its holdings in shares of DaVita by 0.8% in the fourth quarter. Nilsine Partners LLC now owns 11,160 shares of the company’s stock valued at $1,669,000 after acquiring an additional 92 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Stock Performance

Shares of NYSE DVA opened at $153.15 on Thursday. The company has a market cap of $12.25 billion, a PE ratio of 14.26, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The company has a 50-day simple moving average of $153.05 and a 200-day simple moving average of $156.75.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, equities analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have recently weighed in on DVA shares. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. StockNews.com raised shares of DaVita from a “hold” rating to a “buy” rating in a report on Thursday. Cowen reaffirmed a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Barclays boosted their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.